Eric D Jacobsen, MD^1*, Pier Luigi Zinzani, MD, PhD², Jasmine Zain, MD³, Monica Mead, MD, BS⁴, Carla Casulo, MD⁵, Giuseppe Gritti, MD, PhD^6*, Lauren C. Pinter-Brown, MD⁷, Koji Izutsu^8*, Marci Daugherty, PharmD^9*, Jonathan E Brammer, MD¹⁰, Neha Mehta-Shah, MD, MSCI¹¹, Barbara Pro, MD¹² and Steven M. Horwitz, MD¹³

¹Dana Farber Cancer Institute, Harvard Medical School, Boston, MA
²Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy
³City of Hope,, Department of Hematology and Hematopoietic Cell Transplantation, Duarte, CA
⁴Department of Medicine, Division of Hematology/Oncology, UCLA Medical Center, Santa Monica, CA
⁵University of Rochester Medical Center, Rochester, NY
⁶Hematology and Bone Marrow Transplant Unit, ASST Papa Giovanni XXIII, Bergamo, Italy
⁷University of California, Irvine, CA
⁸National Cancer Center Hospital, Tokyo, Japan
⁹Secura Bio, Inc, Carmel, IN
¹⁰Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
¹¹Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
¹²Department of Hematology and Oncology, Columbia University Medical Center, New York, NY
¹³Memorial Sloan Kettering Cancer Center, New York, NY

Charlotte B Wagner, PharmD^1*, Daniel A. Ermann, MD², Ken Boucher, PhD^3*, Adrienne N. Nedved, PharmD^4*, Ivana N. Micallef, MD⁵, Sanjal H Desai, MBBS⁶, Haris Hatic, DO⁷, Gaurav Goyal, MD⁸, Erin Zacholski, PharmD^9*, Amanda Fegley, PharmD^10*, Audrey M. Sigmund, MD¹¹, David A. Bond, MD, BS¹¹, Courtney Samuels, PharmD^12*, Manali K. Kamdar, MD¹³, Sheeba Ba Aqeel, MD¹⁴, Pallawi Torka, MD¹⁴, Kira MacDougall, MD¹⁵, Azra Borogovac, MD¹⁶, Sridevi Rajeeve, MD¹⁷, Suchitra Sundaram, MD¹⁸, Kalub Fedak, MD¹⁹, Dipenkumar Modi, MD²⁰, Elizabeth Travers, PharmD^21*, Sabarish Ayyappan, MD^22*, Nitin Chilakamarri, MD^23*, Elizabeth A Brem, MD²⁴, Deborah M. Stephens, DO²⁵, Boyu Hu, MD^26*, Lindsey A. Fitzgerald, MD²⁷ and Harsh Shah, DO²⁸

¹University of Utah Huntsman Cancer Institute, Salt Lake City, UT
²Department of Hematology/Oncology, Huntsman Cancer Institute, University of Utah, Omaha, NE
³Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake Cty, UT
⁴Department of Pharmacy, Mayo Clinic, Rochester, MN
⁵Division of Hematology, Mayo Clinic, Rochester, MN
⁶University of Minnesota, Division of Hematology Oncology Transplantation, Minneapolis, MN
⁷University of Alabama Medicine, Birmingham, AL
⁸Hematology/Oncology, University of Alabama At Birmingham, Birmingham, AL
⁹Virginia Commonwealth University, Richmond, VA
¹⁰Virginia Commonwealth University Health, Richmond, VA
¹¹Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
¹²University of Colorado Cancer Center, Aurora, CO
¹³University of Colorado Cancer Center, Denver, CO
¹⁴Roswell Park Comprehensive Cancer Center, Buffalo, NY
¹⁵University of Oklahoma Health, Oklahoma City, OK
¹⁶Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK
¹⁷Division of Hematology and Oncology - Department of Medicine, Icahn School of Medicine At Mount Sinai Hospital, New York, NY
¹⁸Tisch Cancer Institute at Mount Sinai, New York, NY
¹⁹Karmanos Cancer Institute, Detroit, MI
²⁰Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute/Wayne State University, Detroit, MI
²¹University of Kentucky HealthCare, Lexington, KY
²²Division of Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
²³University of California Irvine Health, Irvine, CA
²⁴Division of Hematology/Oncology, Dept. of Medicine, University of California, Irvine, Orange, CA
²⁵Huntsman Cancer Institute, Salt Lake City, UT
²⁶Division of Hematology and Hematologic Malignancies, University of Utah, Huntsman Cancer Institute, Salt Lake City, UT
²⁷Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT
²⁸Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, University of Utah, Salt Lake City, UT

Gao Yan, PhD¹, Cheng Huang^2*, Xue-Ping Li^3*, Xiaoxiao Wang, MD^4*, Bing Bai^2*, Yanxia He^2*, Liqin Ping^2* and Huiqiang Huang, MD, PhD⁵

¹Department of Medical Oncology, Sun Yat-Sen University Cancer Center, GuangZhou, China
²Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
³lixp1@sysucc.org.cn, Guangzhou, China
⁴Department of Medical Oncology, Sun Yat-Sen University Cancer Center, Guangzhou, China
⁵Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China

Lugui Qiu^1*, Jie Jin, PhD², Hong Cen, PhD^3*, Keshu Zhou^4*, Xiaohong Xu^5*, Fei Li^6*, Tao Wu^7*, Haiyan Yang^8*, Zhen Wang^9*, Zhiming Li^10*, Hanying Bao, MD, PhD^11* and Zusheng Xu, PhD^12*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
²Department of Hematology, The First Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
³Department of Medical Oncology, Guangxi Cancer Hospital and of Guangxi Medical University Affiliated Cancer Hospital, Nanning, Guangxi, China
⁴Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
⁵Department of Medical Oncology, Nantong Tumor Hospital, Nantong, China
⁶Department of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
⁷Department of Lymphoma, Guizhou Cancer Hospital, Guiyang, China, Guiyang, China
⁸Department of Lymphoma, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China
⁹Linyi Cancer Hospital, Linyi, China
¹⁰Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China
¹¹Shanghai Yingli Pharmaceutical Co.,Ltd., China, Shanghai, China
¹²Shanghai Yingli Pharmaceutical Co.,Ltd., Shanghai, China

Marcus Gerlach, PhD^1*, Saskia Schmitt, PhD^1*, Philipp Cyprys, PhD^1*, Marc-André Kasper, PhD^1*, Isabelle Mai^1*, Maarten H. Vermeer, MD, PhD^2*, Steven M. Horwitz, MD³, Guenter R Fingerle-Rowson, MD PhD¹, Annette Vogl, PhD^1*, Dominik Schumacher, PhD^1* and Jonas Helma-Smets, PhD^1*

¹Tubulis GmbH, Planegg/Martinsried, Germany
²Dept. of Dermatology, Leiden University Medical Center, Leiden, Netherlands
³Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Hun Ju Lee, MD¹, Jeremy S. Abramson, MD², Nancy L. Bartlett^3*, John M. Burke, MD⁴, Ryan C. Lynch, MD^5*, Domingo Domenech Eva, MD^6*, Brian T. Hess, MD⁷, Steven R. Schuster, MD^8*, Yuliya Linhares, MD^9*, Rod Ramchandren, MD¹⁰, Mitul Gandhi, MD¹¹, Rex Mowat^12*, Harsh Shah, DO¹³, Giuseppe Rossi, MD¹⁴, Uwe H Hahn, MBBS, MD, FRCPA^15*, Henry Miles Prince^16*, Linda Ho, MD¹⁷, Wenchuan Guo^17*, Christopher A. Yasenchak, MD¹⁸ and David J. Straus, MD¹⁹

¹Department of Lymphoma & Myeloma, MD Anderson Cancer Center, Houston, TX
²Massachusetts General Hospital, Boston, MA
³Siteman Cancer Center, Washington University School of Medicine, St Louis, MO
⁴Rocky Mountain Cancer Centers, US Oncology Research, Aurora, CO
⁵Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA
⁶Department of Hematology, Institut Catala d’Oncologia. Hospital Duran i Reynals. IDIBELL, Barcelona, Barcelona, Spain
⁷Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
⁸UCHealth Poudre Valley Hospital, Fort Collins, CO
⁹Miami Cancer Institute at Baptist Health, Inc., Miami, FL
¹⁰University of Tennessee Medical Center, Knoxville, TN
¹¹Virginia Cancer Specialists, US Oncology Research, Gainesville, VA
¹²Toledo Clinic Cancer Center, Toledo, OH
¹³Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹⁴Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
¹⁵Royal Adelaide and Queen Elizabeth Hospital, Adelaide, Australia
¹⁶Epworth Freemasons, Melbourne, Australia
¹⁷Seagen Inc., Bothell, WA
¹⁸Willamette Valley Cancer Institute and Research Center, Eugene, OR
¹⁹Memorial Sloan-Kettering Cancer Center, New York, NY

Danai Dima, MD^1,2, Fauzia Ullah, MD^1*, Najiullah Omar, MD^1*, Carmelo Gurnari, MD^1,3*, Puneet Dhillon, DO^4*, Valeria Visconte, PhD¹, Babal K. Jha, PhD, MPhil, MSc, BSc^1,5* and Jaroslaw P. Maciejewski, MD, PhD, FACP^1,2

¹Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
²Department of Hematology and Medical Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
³Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
⁴Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
⁵Center for Immunotherapy & Precision Immuno-Oncology, Cleveland Clinic, Lerner Research Institute, Cleveland, OH

Jaewon Hyung, MD^1*, Jwa Hoon Kim^2*, Hyungwoo Cho^3*, Jin Sook Ryu^4*, Jooryung Huh^5*, Chan-Sik Park^5*, Sang-wook Lee^6*, Yoon Se Lee^7* and Cheolwon Suh³

¹Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
²Deparment of Oncology-Hematology, Korea University Anam Hospital, Seoul, Korea, Republic of (South)
³Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁴Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁵Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁶Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁷Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)

Christopher N Nguyen^1*, Rishab Prakash, BS^2*, Madeleine Duvic, MD³, Meghan Heberton, MD^4*, Julia Dai^5*, Ranjit Nair, MD⁶, Luis Enrique Malpica Castillo, MD⁷, Carlos Torres Cabala, MD^8*, Lei Feng, MS^9*, Swaminathan Padmanabhan Iyer, MD^10* and Auris Huen, MD, PharmD^5*

¹Internal Medicine, Northside Hospital Gwinnett, Atlanta, GA
²The University of Texas MD Anderson Cancer Center, Houston, TX
³The University of Texas M.D. Anderson Cancer Center, Houston, TX
⁴Department of Dermatology, MD Anderson Cancer Center, Houston, TX
⁵Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Pearland, TX
⁷Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Pathology, Division of Pathology-Lab Medicine Div, MD Anderson Cancer Center, Houston, TX
⁹Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Peyton Venneman^1*, Makayla Schissel, MPH^2*, Melissa A. Acquazzino, MD³ and Chittalsinh M Raulji, MBBS^4,5

¹Pediatric Hematology Oncology, University of Nebraska Medical Center, Omaha, NE
²College of Public Health, University of Nebraska Medical Center, Omaha, NE
³Children's Hospital and Medical Center, Omaha, NE
⁴University of Nebraska Medical Center, Omaha, NE
⁵University of Nebraska Medical Center / Children's Hospital and Medical Center, Omaha, NE

Firas Baidoun, MD¹, Jason Sluzevich, M.D.^2*, Han W. Tun, MD³ and Mohamad Alhaj Moustafa, MD⁴

¹Division of Hematology and Medical Oncology, Mayo Clinic Florida, Westlake, OH
²Department of Dermatology, Mayo Clinic Health System, Jacksonville, FL
³Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
⁴Division of Hematology and Medical Oncology, Mayo Clinic-Florida, Jacksonville, FL

Joachim Baech, MD^1*, Lasse Hjort Jakobsen, MSc, PhD^1,2*, Tarec Christoffer Christoffer El-Galaly, MD, DSc^1,2,3, Daniel Molin^4*, Ingrid Glimelius, MD, PhD^4*, Joshua P P. Entrop^5*, Michael Crowther^6,7*, Karin Ekstroem Smedby, MD, PhD^5,8*, Sandra Eloranta, MSc, PhD^5* and Caroline E. Weibull, MSc, PhD^5*

¹Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
²Department of Clinical Medicine, Aalborg University, Aalborg, Denmark
³Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark
⁴Department of Immunology, Genetics, and Pathology, Clinical and Experimental Oncology, Uppsala University, Uppsala Akademiska Hospital, Uppsala, Sweden
⁵Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
⁶Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
⁷Red Door Analytics AB, Stockholm, Sweden
⁸Department of Hematology, Karolinska University Hospital, Solna, Sweden

Zhong Goh, MD^1*, Maya Latimer, MBBS, FRACP, FRCPA^2,3*, Katharine L. Lewis, MBBS, MRCP, FRCPath^4,5,6, Chan Yoon Cheah, DMSc^6,7*, Pietro Di Ciaccio, MBBS, FRACP, FRCPA^8,9,10, Tania Cushion^11*, Eliza Hawkes, MD^12,13, Sean Harrop, MBBS^14*, Matthew Ku, MBBS PhD^15,16, Ashlea Campbell, BSc MBBS FRACP FRCPA^17*, Nada Hamad, MB.BS, FRACP, FRCPA^8,18,19*, Erica M. Wood, MBBS, FRACP, FRCPA^20,21, Eliza Chung^12*, Pin-Yen Chen, BBiomedSc (Hons), PhD^21* and Tara Cochrane, MBBS^22,23

¹Department of Haematology, Gold Coast University Hospital, Southport, QLD, Australia
²ACT Pathology, Canberra, Australia
³The Canberra Hospital, Canberra, Australia
⁴Department of Haematology, Sir Charles Gairdner Hospital, West Leederville, Australia
⁵Linear Clinical Research, Nedlands, Western Australia, Australia
⁶Division Medical School, University of Western Australia, Perth, Australia
⁷Linear Clinical Research and Sir Charles Gairdner Hospital, Perth, AUS
⁸University of New South Wales, Sydney, Australia
⁹Australian National University, Canberra, Australia
¹⁰Department of Haematology, Sydney Adventist Hospital, Sydney, Australia
¹¹Olivia Newton John Cancer Research and Wellness Centre, Heidelberg, VIC, AUS
¹²School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
¹³Olivia Newton John Cancer Research and Wellness Centre, Austin Health, Heidelberg, AUS
¹⁴Department of Haematology, St Vincent's Hospital Melbourne, Melbourne, Australia
¹⁵University of Melbourne, Melbourne, Australia
¹⁶Department of Haematology, St Vincent's Hospital Melbourne, Melbourne, VIC, Australia
¹⁷Dept of Haematology and Bone Marrow Transplant, St Vincents Hospital, Sydney, Australia
¹⁸School of Medicine, University of Notre Dame, Sydney, Australia
¹⁹Department of Haematology, St. Vincent’s Hospital, Sydney, NSW, Australia
²⁰Department of Clinical Haematology, Monash Health, Melbourne, VIC, Australia
²¹Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
²²Griffiths University, Gold Coast, QLD, Australia
²³Department of Haematology, Gold Coast University Hospital, Southport, Australia

Firas Baidoun, MD¹, Bradford Hoppe, MD, MPH^2*, Han W. Tun, MD³ and Mohamad Alhaj Moustafa, MD⁴

¹Division of Hematology and Medical Oncology, Mayo Clinic Florida, Westlake, OH
²Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL
³Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
⁴Division of Hematology and Medical Oncology, Mayo Clinic-Florida, Jacksonville, FL

Swetha Kambhampati, MD¹, Matthew Mei, MD², Lu Chen, PhD^3*, Sandrine Puverel, PhD^4*, Robert Chen, MD⁵, Leslie L. Popplewell, MD, FACP, MPH⁶, Liana Nikolaenko, MD⁷, Lacolle Peters^4*, Saro H. Armenian, DO, MPH⁸, Larry W. Kwak, MD, PhD⁹, Steve T Rosen, MD¹⁰, Stephen J Forman, MD¹¹ and Alex F. Herrera, MD¹²

¹City of Hope National Medical Center, DUARTE, CA
²Division of Lymphoma, City of Hope Medical Center, Duarte, CA
³Department of Information Sciences, City of Hope, Duarte
⁴City of Hope, Duarte, CA
⁵City of Hope National Medical Center, Duarte, CA
⁶Department of Hematology/Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁷Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁸Department of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte, CA
⁹Deputy Director, City of Hope Comprehensive Cancer Center, Duarte, CA
¹⁰Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
¹¹Department of Hematology and Hematopoietic Stem Cell Transplantation, Beckman Research Institute., City of Hope National Medical Center, Duarte, CA
¹²Department of Hematology and Hematopoietic Cell Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA

Domingo Domenech Eva, MD^1,2*, Marta Bellver, MD^3*, German Ferrer, MD^4*, Eva Gonzalez Barca, MD, PhD^5,6,7*, Itziar Carro, MD^8*, Ana C Oliveira, MD, PhD^9*, Patricia Lopez, MD^10*, Gabriela Sanz-Linares, MD^10*, Carmen Aguilera^11*, Montserrat Alemany, MD^12*, Inmaculada Peiro, MD^3*, Anna Sureda^13,14 and Roser Velasco, MD, PhD^4*

¹Department of Hematology, Institut Catala d’Oncologia. Hospital Duran i Reynals. IDIBELL, Barcelona, Barcelona, Spain
²Department of Clinical Hematology, Institut Català d’Oncologia – Hospital Duran I Reynals, IDIBELL, Barcelona, Spain
³Clinical Nutrition Unit. Institut Catala d'Oncologia. Hospital Duran i Reynals. IDIBELL, Hospitalet de Llobregat, Spain
⁴Unit of Neurooncology. Institut Catala d'Oncologia. Hospital Duran i Reynals. IDIBELL, Hospitalet de Llobregat, Spain
⁵Hospital Duran i Reynals, INSTITUT CATALA D'ONCOLOGIA, BARCELONA, ESP
⁶Departament de Ciencies Cliniques, Universitat de Barcelona., Barcelona, Spain
⁷Institut Català d’Oncologia – Hospitalet, IDIBELL, Barcelona, Spain
⁸Hematology, Institut Catala d'Oncologia. Hospital Duran i Reynals. IDIBELL, Hospitalet de Llobregat, Spain
⁹Department of Hematology, Institut Català d'Oncologia, L'Hospitalet de LLobregat, Hospitalet de Llobregat, Spain
¹⁰Department of Clinical Hematology. Institut Catala d'Oncologia. Hospital Duran i Reynals. IDIBELL, Hospitalet de Llobregat, Spain
¹¹Hematology, Institut Catala d’Oncologia. Hospital Duran i Reynals. IDIBELL, Hospitalet de Llobregat, Spain
¹²Neurooncology Unit. Institut Catala d'Oncologia. Hospital Duran i Reynals. IDIBELL, Hospitalet de Llobregat, Spain
¹³Hematology Department, Institut Català d'Oncologia - Hospital Duran i Reynals, Barcelona, Spain
¹⁴Institut Català d'Oncologia, Hospital Duran i Reynals. Institut d’Investigació Biomèdica de Bellvitge (IDIBELL). Universitat de Barcelona, Barcelona, Spain

Matko Kalac, MD, PhD¹, Salvia Jain, MD², Constantine S. Tam, MD, MBBS³, Mendel Goldfinger, MD⁴, Zhengrui Xiao, MD⁵, Francesca Montanari, MD⁶, Bryan D. Huber, MD^7*, Jennifer A. Kanakry, MD^8*, Owen A. O'Connor, MD, PhD⁹ and Enrica Marchi, MD, PhD⁹

¹UCI Health Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA
²Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA
³Peter MacCallum Cancer Centre, Kew, VIC, Australia
⁴Department of Hematology and Medical Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, NY
⁵Department of Hematology-Oncology, Montefiore Medical Center, Bronx, NY
⁶Smilow Cancer Hospital - Greenwich, Yale School of Medicine and Yale Cancer Center, Greenwich, CT
⁷Intermoutain Blood & Marrow Transplant/Acute Leukemia Program, LDS Hospital, Salt Lake City, UT
⁸Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, MD
⁹Program for T-Cell Lymphoma Research, University of Virginia, Charlottesville, VA

Nathan Roberts, MD¹, John Lister, MD², N. Nora Nora Bennani, MD³, Salvia Jain, MD⁴, Tammy Battaglia, BA^1*, Emily C. Ayers, MD¹, Craig A. Portell, MD¹, Michael E. Williams, MD¹, Prem Batchala, MD^5*, Ipsita Pal, PhD^6*, Owen A. O'Connor, MD, PhD⁶, John Sanil Manavalan, MD^6* and Enrica Marchi, MD, PhD⁶

¹Division of Hematology and Oncology, Department of Medicine, University of Virginia, Charlottesville, VA
²Division of Hematology and Cellular Therapy, Allegheny Health Network Cancer Institute, Pittsburgh, PA
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA
⁵Division of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA
⁶Program for T-Cell Lymphoma Research, University of Virginia, Charlottesville, VA

Miao Zheng, MD, PhD^1*, Peiling Zhang, MD^1*, Yaxian Ma^2*, Yuhan Bao^1*, Hui Luo^1*, Jiachen Wang^1* and Liang Huang, MD¹

¹Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
²Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Tech, Wuhan, Hubei, China

Seisha Alana Von Glasenapp Gossen^1*, Humberto Martinez-Cordero, MD, MSc², Luis Villela, MD^3*, Perla Rocio Colunga-Pedraza, MD⁴, Fernando Perez-Jacobo, MD^5*, Arianna Robles, MD^6*, Diego Fernando Garces PAZ, Medical Doctor^7*, Henry Idrobo, MD^8*, Denisse Castro, MD⁹, Sally Rose Paredes, MD^10*, Brady E Beltran, MD^11*, Ana Carolina Oliver, MD¹², Victoria Irigoin, MD^13*, Juan Alejandro Ospina, MD^14,15* and Rosa Oliday Rios, Medical Doctor^16*

¹Department of Hematology, INSTITUTO DE PREVISION SOCIAL, Assunción, Paraguay
²15Instituto Nacional de Cancerologia, Bogota, Colombia, bogota, Colombia
³Escuela De Medicina Del Tecnologico De Monterrey, Centro Medico Zambrano Hellion, Hermosillo, NL, Mexico
⁴Servicio de Hematología, Universidad Autonoma de Nuevo Leon, Hospital Universitario "Dr. José Eleuterio Gonzalez", Monterrey, Mexico
⁵Hematology and blood bank services, Hospital Central Norte PEMEX, CDMX, Mexico
⁶Universidad de Guadalajara, CUCS, HGO, Zapopan, MEX
⁷CAUCA COLOMBIA, CAUCA, Colombia
⁸Facultad de Medicina., Universidad Del Valle, Cali, Colombia
⁹Hospital Edgardo Rebaglati Martins, lima, Peru
¹⁰Centro de Investigacion de Medicina de Precision, Universidad de San Martin de Porres, LIMA, Peru
¹¹Departamento de Oncología y Radioterapia, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
¹²Hospital britanico, montevideo, Uruguay
¹³HEmatology Department, Hospital Britanico CASMU, montevideo, Uruguay
¹⁴Los Cobos Medical Center, Universidad del Bosque, cali, Colombia
¹⁵National Cancer Institute, BOGOTA, Colombia
¹⁶Sociedad Científica de Hematología de Cuba, Cuba, Cuba

Pamela B. Allen, MD¹, Subir Goyal, PhD^2*, Swaminathan P. Iyer, MD³, Sai Talluru, MD^4*, Auris Huen, MD, PharmD^5*, Irl Brian Greenwell, MD⁶, Jane Scribner, MD^7*, Shel Speegle, MS^8*, Tim Niyogusaba, BA^9*, Sunil Rangarajan, MD^10*, Amitkumar Mehta, MD¹¹, Colin B. O'Leary, MA^8*, Anne W. Beaven, MD¹², Jeffrey M. Switchenko, PhD, MS^13*, Amy Ayers, MPH^3*, Safiyyah Bhatti^14*, Shalini Krishnasamy, MD^15*, Pierluigi Porcu, MD¹⁶, Tarsheen Sethi, MD, MBBS, MSc¹⁷, Francine M. Foss, MD¹⁸, Mary Jo Lechowicz, MD¹⁹ and Sima Rozati, MD, PhD^4*

¹Winship Cancer Institute, Department of Hematology Oncology, Emory University, Atlanta, GA
²Biostatistics and Bioinformatics, Winship Cancer Institute of Emory University, Atlanta, GA
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Dermatology, Johns Hopkins Medical Center, Baltimore, MD
⁵Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
⁷Dermatology, Medical University of South Carolina, Charleston
⁸Winship Cancer Institute of Emory University, Atlanta, GA
⁹Department of Medicine, Emory University School of Medicine, Atlanta, GA
¹⁰University of Alabama, Birmingham, AL
¹¹Division of Hematology/Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
¹²Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
¹³Departments of Biostatistics and Bioinformatics, Emory University School of Medicine, Atlanta, GA
¹⁴Hematology Oncology, Jefferson University, Philadephia, PA
¹⁵Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadephia
¹⁶Sidney Kimmel Cancer Center at Jefferson Health, Thomas Jefferson University, Philadelphia, PA
¹⁷Smilow Cancer Hospital at Yale New Haven, New Haven, CT
¹⁸Hematology, Yale Cancer Center, Hamden, CT
¹⁹Hematology & Medical oncology, Emory University School of Medicine, Atlanta, GA

Philip A Haddad, MD and Nowell Ganey, MD^*

LSUHSC-S/Overton Brooks VAMC, Shreveport, LA

Ayumi Fujimoto, MD^1*, Takeshi Maeda, MD, PhD^2*, Noriko Fukuhara, MD, PhD³, Kana Miyazaki, MD, PhD⁴, Motoko Yamaguchi, MD, PhD⁵, Fumihiro Ishida, MD, PhD⁶ and Ritsuro Suzuki, MD, PhD⁷

¹Department of Hematology, Shimane University Hospital, Izumo, Japan
²Department of Hematology and Oncology, Kurashiki Central Hospital, Kurashiki, Japan
³Department of Hematology, Tohoku University Hospital, Sendai, Japan
⁴Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan
⁵Department of Hematological Malignancies, Mie University Graduate School of Medicine, Tsu, Japan
⁶Department of Biomedical Laboratory Sciences, Shinshu University School of Medicine, Matsumoto, Japan
⁷Department of Hematology, Shimane University Hospital, Izumo, Japan

Jowon Laura Kim, MD^1*, Diego Villa, MD², R. Petter Tonseth, MD^3*, Alina S. Gerrie, MD, MPH, FRCPC⁴, Don Wilson, MD^3*, Francois Benard, MD^3*, Christopher P. Venner, MD, FRCPC⁴, Brian Skinnider, MD, FRCPC^5*, Pedro Farinha, MD, PhD^5*, Graham W. Slack, MD⁵, Randy D. Gascoyne, MD^5*, David W. Scott, PhD, MD, FRACP, FRCPA², Joseph M. Connors, MD, FRCPC⁴, Laurie H. Sehn, MD, MPH⁴ and Kerry J. Savage, MD, MSc, FRCPC⁴

¹Department of Medicine, University of British Columbia, Vancouver, BC, Canada
²British Columbia Cancer Agency, Vancouver, BC, Canada
³Department of Functional Imaging, BC Cancer Agency, Vancouver, BC, Canada
⁴BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
⁵Centre for Lymphoid Cancer and Department of Pathology, BC Cancer, Vancouver, BC, Canada

Rosa Rönkkö, MD^1,2,3*, Aapeli Nevala, MSc^4*, Outi Kilpivaara, PhD^5,6,7, Janne Pitkäniemi, PhD^4,8,9*, Nea Malila, MD, PhD^4* and Ulla Wartiovaara-Kautto, MD, PhD^2,10

¹Department of Internal Medicine, Helsinki University Hospital, Helsinki, Finland
²Department of Hematology, University of Helsinki, Helsinki, Finland
³Finnish Cancer Registry, Cancer Society of Finland, Helsinki, AL, Finland
⁴Finnish Cancer Registry, Cancer Society of Finland, Helsinki, Finland
⁵HUS Diagnostic Center (Helsinki University Hospital), HUSLAB Laboratory of Genetics, University of Helsinki, Helsinki, Finland
⁶Applied Tumor Genomics (ATG) Research Program, Research Programs Unit, University of Helsinki, Helsinki, Finland
⁷Department of Medical and Clinical Genetics / Medicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland
⁸Faculty of Social Sciences, Tampere University, Helsinki, Finland
⁹Department of Public Health, University of Helsinki, Helsinki, Finland
¹⁰Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki, Finland

Young Gyu Park, MD^1*, Hyungwoo Cho, MD^1*, Jin Sook Ryu^2*, Chan-Sik Park^3*, Sang-wook Lee^4*, Yoon Sei Lee^5*, Yoon Seok Choi, MD, PhD⁶ and Dok Hyun Yoon, MD, PhD^1*

¹Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
²Department of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
³Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁴Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁵Department of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁶Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea, Republic of (South)